These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32898856)

  • 1. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Isenberg DA
    Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
    Cohen H; Efthymiou M; Devreese KMJ
    J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
    Sayar Z; Moll R; Isenberg D; Cohen H
    Thromb Res; 2021 Feb; 198():213-221. PubMed ID: 33485122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
    Sayar Z; Burke S; Mittal P; Cohen H
    Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Sayar Z; Efthymiou M; Gaspar P; Richards T; Isenberg D
    Lancet Haematol; 2020 Aug; 7(8):e613-e623. PubMed ID: 32735839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
    Anderson M; Belmont HM
    Lupus; 2022 Feb; 31(2):261-267. PubMed ID: 35041558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature.
    Marco-Rico A; Marco-Vera P
    Semin Thromb Hemost; 2023 Oct; 49(7):736-743. PubMed ID: 36996874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation.
    Bakow BR; Yanek L; Crowther MA; Chaturvedi S
    Thromb Res; 2024 May; 237():88-93. PubMed ID: 38569453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic antiphospholipid syndrome: From guidelines to clinical management.
    Paredes-Ruiz D; Martin-Iglesias D; Ruiz-Irastorza G
    Med Clin (Barc); 2024 Aug; 163 Suppl 1():S22-S30. PubMed ID: 39174150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.